Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Aporti, Pietro
DOB: 07-JAN-1936 (Age: 90)
Gender: male
Address:
Contrada Damiano, 24 Appartamento 91
28802 Mergozzo (Italy)
ID: 5026-215779-0 (ECI)
Report
Date: 06-NOV-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Presidio ospedalieri G. Castelli
Via Fiume 18
28922 Verbania (Italy)
Specimen
Collected: 06-NOV-2023

Chemistry

Test 06-NOV-2023 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 209.7 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 128.6 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 133.9 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.1 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated total cholesterol and LDL cholesterol, while triglycerides and HDL are within normal limits. This lipid profile suggests increased cardiovascular risk; lipid-lowering therapy and lifestyle modifications should be considered in the context of overall health and comorbidities. Regular monitoring is recommended.